Skip to main content
. 2014 Jul 8;111(5):858–865. doi: 10.1038/bjc.2014.370

Figure 1.

Figure 1

(A) Observed gemcitabine plasma concentrations (μg l−1) vs time (h) after intravenous infusion of 10 mg m−2 min−1 on day 1. (B) Observed gemcitabine plasma concentrations (μg l−1) vs time (h) after intravenous infusion of 10 mg m−2 min−1 on day 21.